Showing results (111-120 of 222) with videos related to
Sort By:
Pageof 23
Investigational New Drugs|August 4, 2010
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesElisabeth I Heath, Patricia Lorusso, Suresh S Ramalingam, et al.Journal of the National Cancer Institute|April 5, 2007
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trialElisabeth I Heath, Marcia Irene Canto, Steven Piantadosi, et al.JCO Precision Oncology|July 6, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsDeborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, et al.American Journal of Translational Research|April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patientsClara Hwang, Seema Sethi, Lance K Heilbrun, et al.Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.Oncotarget|November 20, 2018
Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progressionAmro Aboukameel, Irfana Muqbil, Erkan Baloglu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate CancerUlka N Vaishampayan, Izabela Podgorski, Lance K Heilbrun, et al.Cancer Chemotherapy and Pharmacology|January 22, 2016
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumorsJustine Yang Bruce, Patricia M LoRusso, Priscila H Goncalves, et al.Clinical Pharmacology and Therapeutics|October 29, 2010
A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumorsE I Heath, E G Chiorean, C J Sweeney, et al.The Medical Journal of Australia|October 6, 2001
Adult-to-adult living donor liver transplantation for fulminant hepatic failureA K House, G P Jeffrey, K A Edyvane, et al.Pageof 23